2026年全球醫藥供應鏈管理市場報告

近年來，醫藥供應鏈管理市場發展迅猛，預計將以 8.3% 的複合年成長率成長，從 2025 年的 28.5 億美元成長到 2026 年的 30.8 億美元。過去幾年成長要素包括醫藥生產的擴張、醫療設施的擴張、對安全藥品分銷需求的增加、ERP 系統的引入以及學名藥產量的增加。

預計未來幾年，醫藥供應鏈管理市場將維持強勁成長，2030年市場規模將達到42.2億美元，複合年成長率（CAGR）為8.1%。預測期內的成長要素包括人工智慧在供應鏈中的應用、預測分析的普及、生物製藥和疫苗的推廣、個人化醫療的進步以及對端到端追蹤溯源解決方案日益成長的需求。預測期內的關鍵趨勢包括低溫運輸最佳化、自動化合規、即時庫存視覺化、供應商協作以及醫藥分銷風險管理。

慢性病發病率的不斷上升預計將推動醫藥供應鏈管理市場的擴張。慢性病是指需要持續治療、長期服藥和頻繁醫療監測的長期健康狀況，例如糖尿病、高血壓和心血管疾病。慢性病發生率的上升是由於人口老化、生活方式相關風​​險、代謝性疾病的增加。醫藥供應鏈管理透過確保穩定的藥品供應、避免藥物短缺以及改善長期治療的藥物輸送，從而支持患者的治療效果。例如，根據英國政府機構國家醫療服務體系（NHS）發布的數據，截至2024年6月，2023年在全科醫生（GP）註冊的3,615,330名患者患有非糖尿病性高血糖或糖尿病前期（血糖水平高但未達到糖尿病診斷標準），比前一年的3,065,825例增加了18%。因此，慢性病負擔的加重正在推動醫藥供應鏈管理市場的成長。

為了滿足對敏感藥品安全、高效且合規管理的日益成長的需求，醫藥供應鏈管理市場的主要企業正優先開發尖端解決方案，例如溫控物流平台。這些平台結合了先進的低溫運輸技術、即時溫度追蹤和預測分析，確保藥品、疫苗和生物製藥在儲存和運輸過程中始終保持在所需的溫度範圍內，從而最大限度地減少廢棄物並維持合規標準。例如，2025年8月，印度物流與供應鏈專家Celsius 物流推出了專為藥品設計的尖端低溫運輸服務Celsius Plus。 Celsius Plus利用物聯網感測器、人工智慧驅動的路線最佳化和雲端監控，在整個供應鏈中保持精確的溫度水平，確保藥品從生產到交付給最終用戶的整個過程中的有效性和安全性。該服務提供即時通知、全面的合規文件和靈活的擴充性，以適應各種規模的貨物運輸，因此適用於小規模和大規模藥品運輸。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球醫藥供應鏈管理市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 人工智慧（AI）和自主人工智慧
  • 工業4.0和智慧製造
  • 物聯網、智慧基礎設施和互聯生態系統
  • 數位化、雲端運算、巨量資料、網路安全
  • 生物技術、基因組學和精準醫學
• 主要趨勢
  • 低溫運輸最佳化
  • 自動化監管合規
  • 即時庫存可見性
  • 與供應商和供應商的合作
  • 藥品分銷中的風險管理

第5章 終端用戶產業市場分析

• 製藥公司
• 醫療保健提供者
• 經銷商
• 物流服務供應商
• 研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球醫藥供應鏈管理市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球醫藥供應鏈管理市場規模、比較及成長率分析
• 全球醫藥供應鏈管理市場表現：規模與成長，2020-2025年
• 全球醫藥供應鏈管理市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 按組件
• 解決方案和服務
• 透過部署模式
• 本機部署和雲端部署
• 按最終用途
• 醫療設備製造商、醫療保健提供者、經銷商和物流
• 按類型細分：解決方案
• 供應鏈管理軟體、庫存管理系統、訂單管理系統、運輸管理解決方案、倉庫管理解決方案、追蹤溯源解決方案、需求預測解決方案、低溫運輸監控解決方案
• 按類型細分：服務
• 諮詢服務、整合和實施服務、託管服務、支援和維護服務、物流和交付服務、培訓和教育服務

第10章 區域與國家分析

• 全球醫藥供應鏈管理市場：依地區分類，實際結果與預測，2020-2025年、2025-2030年預測、2035年預測
• 全球醫藥供應鏈管理市場：依國家分類，實際值及預測值，2020-2025年、2025-2030年預測值、2035年預測值

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 醫藥供應鏈管理市場：競爭格局及市場佔有率（2024年）
• 醫藥供應鏈管理市場：公司估值矩陣
• 醫藥供應鏈管理市場：公司概況
  • McKesson Corporation
  • AmerisourceBergen Corporation
  • Cardinal Health Inc.
  • Oracle Corporation
  • SAP SE

第37章：其他領先和創新企業

• DSV Panalpina, UPS Healthcare, Parexel International Corporation, Vizient Inc, Catalent Inc., Infor Inc., Epicor Software Corporation, Vetter Pharma International GmbH, Almac Group, Manhattan Associates Inc., Global Healthcare Exchange LLC, CryoPDP, Tecsys Inc., Arvato Supply Chain Solutions, Terso Solution

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年醫藥供應鏈管理市場：提供新機會的國家
• 2030年醫藥供應鏈管理市場：新興細分市場機會
• 2030年醫藥供應鏈管理市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Pharmaceutical supply chain management involves the planning, implementation, and control of pharmaceutical products' flow and associated information from manufacturers to end-users. It ensures secure distribution of pharmaceuticals while upholding product quality, safety, and adherence to regulatory standards.

The primary elements of pharmaceutical supply chain management consist of solutions and services. A solution denotes a product, service, or strategic method crafted to tackle particular challenges encountered by pharmaceutical companies through a blend of resources, expertise, or technology. Different deployment options include on-premise and cloud-based models, which serve diverse end-users like healthcare manufacturers, healthcare providers, distributors, and logistics providers.

Tariffs have impacted the pharmaceutical supply chain management market by increasing the cost of imported raw materials, packaging, and logistics equipment, thereby affecting the overall supply chain efficiency. High tariffs have particularly affected pharmaceutical manufacturers and distributors in regions heavily reliant on imports, such as north america and europe. Cold chain solutions and inventory management systems are among the most impacted segments due to higher operational costs. However, tariffs have also encouraged local sourcing and investment in domestic manufacturing, potentially improving long-term supply chain resilience.

The pharmaceutical supply chain management market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical supply chain management market statistics, including pharmaceutical supply chain management industry global market size, regional shares, competitors with a pharmaceutical supply chain management market share, detailed pharmaceutical supply chain management market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical supply chain management industry. This pharmaceutical supply chain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical supply chain management market size has grown strongly in recent years. It will grow from $2.85 billion in 2025 to $3.08 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to growing pharmaceutical manufacturing, expansion of healthcare facilities, increasing demand for safe drug distribution, adoption of ERP systems, rise in generic drug production.

The pharmaceutical supply chain management market size is expected to see strong growth in the next few years. It will grow to $4.22 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to integration of ai in supply chain, adoption of predictive analytics, expansion of biologics and vaccines, growth in personalized medicine, increased demand for end-to-end track and trace solutions. Major trends in the forecast period include cold chain optimization, regulatory compliance automation, real-time inventory visibility, vendor and supplier collaboration, risk management in pharmaceutical distribution.

The increasing incidence of chronic diseases is anticipated to fuel expansion in the pharmaceutical supply chain management market. Chronic diseases are enduring health conditions like diabetes, hypertension, and cardiovascular issues that demand sustained treatment, ongoing medication, and frequent medical oversight. This surge stems from aging demographics, lifestyle-induced risks, and growing metabolic conditions. Pharmaceutical supply chain management aids patient outcomes by guaranteeing steady medication availability, avoiding shortages, and enhancing drug delivery for prolonged therapies. For example, in June 2024, the National Health Service-a UK government agency-reported that 3,615,330 patients registered with a general practitioner (GP) had non-diabetic hyperglycemia or pre-diabetes (elevated blood sugar not reaching diabetes levels) in 2023, up 18% from 3,065,825 cases the prior year. Thus, the growing burden of chronic diseases is propelling the pharmaceutical supply chain management market forward.

Major companies in the pharmaceutical supply chain management market are prioritizing the creation of cutting-edge solutions, like temperature-controlled logistics platforms, to address the growing need for secure, streamlined, and regulation-compliant management of delicate pharmaceutical goods. These platforms combine sophisticated cold chain technologies, live temperature tracking, and forecasting analytics to guarantee that medications, vaccines, and biologics stay within required temperature thresholds during storage and transport, minimizing waste and upholding compliance standards. For example, in August 2025, Celcius Logistics Pvt. Ltd., an India-based firm specializing in logistics and supply chains, introduced Celcius+, a state-of-the-art cold chain service tailored for pharmaceuticals. Celcius+ employs IoT sensors, AI-powered path optimization, and cloud monitoring to sustain exact temperature levels throughout the supply chain, preserving drug effectiveness and safety from production to end-user delivery. The service also delivers instant notifications, comprehensive compliance documentation, and flexible scaling for different shipment sizes, catering to both modest and extensive pharmaceutical needs.

In November 2025, DHL Group, a Germany-based contract logistics company, acquired SDS Rx for an undisclosed sum. Through this acquisition, DHL seeks to bolster its life sciences and healthcare logistics platform by incorporating specialized final-mile delivery and time-critical transportation services. Strategic Delivery Solutions LLC is a US-based healthcare logistics provider that focuses on final-mile delivery and high-touch transportation for long-term care and specialty pharmacies.

Major companies operating in the pharmaceutical supply chain management market are McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health Inc., Oracle Corporation, SAP SE, DSV Panalpina, UPS Healthcare, Parexel International Corporation, Vizient Inc, Catalent Inc., Infor Inc., Epicor Software Corporation, Vetter Pharma International GmbH, Almac Group, Manhattan Associates Inc., Global Healthcare Exchange LLC, CryoPDP, Tecsys Inc., Arvato Supply Chain Solutions, Terso Solution, Logitag Systems, Jump Technologies, Chain.io Inc.

Asia-Pacific was the largest region in the pharmaceutical supply chain management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical supply chain management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical supply chain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical supply chain management market includes revenues earned by entities by providing services such as logistics and distribution, cold chain management, inventory management, and quality control and assurance services that are used to optimize the pharmaceutical supply chain for the delivery of vital medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pharmaceutical supply chain management market consists of sales of cold chain equipment, warehouse automation systems, and automated guided vehicles. to provide pharmaceutical companies with opportunities to optimize the supply chain operations of pharmaceutical products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Supply Chain Management Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical supply chain management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical supply chain management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical supply chain management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Solution; Service
• 2) By Deployment Mode: On-Premise; Cloud Based
• 3) By End-Use: Healthcare Manufacturers; Healthcare Providers; Distributors; Logistics
• Subsegments:
• 1) By Solution: Supply Chain Management Software; Inventory Management Systems; Order Management Systems; Transportation Management Solutions; Warehouse Management Solutions; Track And Trace Solutions; Demand Forecasting Solutions; Cold Chain Monitoring Solutions
• 2) By Service: Consulting Services; Integration And Implementation Services; Managed Services; Support And Maintenance Services; Logistics And Distribution Services; Training And Education Services
• Companies Mentioned: McKesson Corporation; AmerisourceBergen Corporation; Cardinal Health Inc.; Oracle Corporation; SAP SE; DSV Panalpina; UPS Healthcare; Parexel International Corporation; Vizient Inc; Catalent Inc.; Infor Inc.; Epicor Software Corporation; Vetter Pharma International GmbH; Almac Group; Manhattan Associates Inc.; Global Healthcare Exchange LLC; CryoPDP; Tecsys Inc.; Arvato Supply Chain Solutions; Terso Solution; Logitag Systems; Jump Technologies; Chain.io Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Supply Chain Management Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pharmaceutical Supply Chain Management Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Supply Chain Management Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pharmaceutical Supply Chain Management Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Biotechnology, Genomics & Precision Medicine
• 4.2. Major Trends
  • 4.2.1 Cold Chain Optimization
  • 4.2.2 Regulatory Compliance Automation
  • 4.2.3 Real-Time Inventory Visibility
  • 4.2.4 Vendor And Supplier Collaboration
  • 4.2.5 Risk Management In Pharmaceutical Distribution

5. Pharmaceutical Supply Chain Management Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Manufacturers
• 5.2 Healthcare Providers
• 5.3 Distributors
• 5.4 Logistics Service Providers
• 5.5 Research Laboratories

6. Pharmaceutical Supply Chain Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Supply Chain Management Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pharmaceutical Supply Chain Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pharmaceutical Supply Chain Management Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pharmaceutical Supply Chain Management Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pharmaceutical Supply Chain Management Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Supply Chain Management Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Supply Chain Management Market Segmentation

• 9.1. Global Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Solution, Service
• 9.2. Global Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• On-Premise, Cloud Based
• 9.3. Global Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Healthcare Manufacturers, Healthcare Providers, Distributors, Logistics
• 9.4. Global Pharmaceutical Supply Chain Management Market, Sub-Segmentation Of Solution, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Supply Chain Management Software, Inventory Management Systems, Order Management Systems, Transportation Management Solutions, Warehouse Management Solutions, Track And Trace Solutions, Demand Forecasting Solutions, Cold Chain Monitoring Solutions
• 9.5. Global Pharmaceutical Supply Chain Management Market, Sub-Segmentation Of Service, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Consulting Services, Integration And Implementation Services, Managed Services, Support And Maintenance Services, Logistics And Distribution Services, Training And Education Services

10. Pharmaceutical Supply Chain Management Market Regional And Country Analysis

• 10.1. Global Pharmaceutical Supply Chain Management Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pharmaceutical Supply Chain Management Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Supply Chain Management Market

• 11.1. Asia-Pacific Pharmaceutical Supply Chain Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Supply Chain Management Market

• 12.1. China Pharmaceutical Supply Chain Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Supply Chain Management Market

• 13.1. India Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Supply Chain Management Market

• 14.1. Japan Pharmaceutical Supply Chain Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Supply Chain Management Market

• 15.1. Australia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Supply Chain Management Market

• 16.1. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Supply Chain Management Market

• 17.1. South Korea Pharmaceutical Supply Chain Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Supply Chain Management Market

• 18.1. Taiwan Pharmaceutical Supply Chain Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Supply Chain Management Market

• 19.1. South East Asia Pharmaceutical Supply Chain Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Supply Chain Management Market

• 20.1. Western Europe Pharmaceutical Supply Chain Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Supply Chain Management Market

• 21.1. UK Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Supply Chain Management Market

• 22.1. Germany Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Supply Chain Management Market

• 23.1. France Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Supply Chain Management Market

• 24.1. Italy Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Supply Chain Management Market

• 25.1. Spain Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Supply Chain Management Market

• 26.1. Eastern Europe Pharmaceutical Supply Chain Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Supply Chain Management Market

• 27.1. Russia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Supply Chain Management Market

• 28.1. North America Pharmaceutical Supply Chain Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Supply Chain Management Market

• 29.1. USA Pharmaceutical Supply Chain Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Supply Chain Management Market

• 30.1. Canada Pharmaceutical Supply Chain Management Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Supply Chain Management Market

• 31.1. South America Pharmaceutical Supply Chain Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Supply Chain Management Market

• 32.1. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Supply Chain Management Market

• 33.1. Middle East Pharmaceutical Supply Chain Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Supply Chain Management Market

• 34.1. Africa Pharmaceutical Supply Chain Management Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pharmaceutical Supply Chain Management Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Supply Chain Management Market Regulatory and Investment Landscape

36. Pharmaceutical Supply Chain Management Market Competitive Landscape And Company Profiles

• 36.1. Pharmaceutical Supply Chain Management Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pharmaceutical Supply Chain Management Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pharmaceutical Supply Chain Management Market Company Profiles
  • 36.3.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. AmerisourceBergen Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. SAP SE Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Supply Chain Management Market Other Major And Innovative Companies

• DSV Panalpina, UPS Healthcare, Parexel International Corporation, Vizient Inc, Catalent Inc., Infor Inc., Epicor Software Corporation, Vetter Pharma International GmbH, Almac Group, Manhattan Associates Inc., Global Healthcare Exchange LLC, CryoPDP, Tecsys Inc., Arvato Supply Chain Solutions, Terso Solution

38. Global Pharmaceutical Supply Chain Management Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Supply Chain Management Market

40. Pharmaceutical Supply Chain Management Market High Potential Countries, Segments and Strategies

• 40.1 Pharmaceutical Supply Chain Management Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pharmaceutical Supply Chain Management Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pharmaceutical Supply Chain Management Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer